Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 1/20 | 0.53 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.46 |
| ▸ | GABRP | O00591 | 2/20 | 0.44 |
| ▸ | GABRD | O14764 | 2/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.44 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.44 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.44 |
| ▸ | GABRE | P78334 | 2/20 | 0.44 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.44 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.44 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.44 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.44 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.43 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27880528 | 1.00 | CTSC (0.53) | CTSCNOD1GABRPGABRDGABRA1 | |
| SCHEMBL31344439 | 1.00 | CTSC (0.53) | CTSCNOD1GABRPGABRDGABRA1 | |
| SCHEMBL10379813 | 0.89 | NOD1 (0.47) | CTSCNOD1GABRPGABRDGABRA1 | |
| SCHEMBL10804597 | 0.89 | CTSC (0.58) | CTSCNOD1GABRPGABRDGABRA1 | |
| SCHEMBL15011502 | 0.89 | CTSC (0.58) | CTSCNOD1GABRPGABRDGABRA1 | |
| SCHEMBL10804587 | 0.89 | CTSC (0.58) | CTSCNOD1GABRPGABRDGABRA1 | |
| SCHEMBL4217551 | 0.85 | NOD1 (0.59) | NOD1GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL7927426 | 0.85 | NOD1 (0.59) | NOD1GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL11103615 | 0.85 | NOD1 (0.59) | NOD1GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL27892995 | 0.85 | NOD1 (0.59) | NOD1GABRPGABRDGABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0135376-B1 | POLYOXYPROPYLENE-POLYOXYETHYLENE BLOCK POLYMER BASED ADJUVANTS AND VACCINES USING THEM | SYNTEX (U.S.A.) INC. (US) | 1990-11-07 | — | — | EP | claimed |
| US-20250345410-A1 | VACCINATION IN NEWBORNS AND INFANTS | CureVac SE (DE) | 2025-11-13 | — | — | US | disclosed |
| WO-2023213393-A1 | STAPHYLOCOCCAL PROTEIN VARIANTS AND TRUNCATES | EVAXION BIOTECH A/S (DK) | 2023-11-09 | — | — | WO | disclosed |
| US-11672856-B2 | Vaccination in newborns and infants | CureVac SE (DE) | 2023-06-13 | — | — | US | disclosed |
| EP-4189686-A2 | PROCESS FOR PREPARATION OF NEOPEPITOPE-CONTAINING VACCINE AGENTS | Evaxion Biotech A/S (DK) | 2023-06-07 | — | — | EP | disclosed |
| WO-2022032099-A9 | NEISSERIAL SURFACE PROTEIN A (NSPA) VARIANTS AND METHODS OF USE THEREOF | CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND (US) | 2022-09-15 | — | — | WO | disclosed |
| EP-4028763-A1 | METHOD FOR IDENTIFYING T-CELL EPITOPES | Evaxion Biotech A/S (DK) | 2022-07-20 | — | — | EP | disclosed |
| WO-2022023521-A2 | PROCESS FOR PREPARATION OF NEOPEPITOPE-CONTAINING VACCINE AGENTS | EVAXION BIOTECH A/S (DK) | 2022-02-03 | — | — | WO | disclosed |
| WO-2021048400-A1 | METHOD FOR IDENTIFYING T-CELL EPITOPES | EVAXION BIOTECH APS (DK) | 2021-03-18 | — | — | WO | disclosed |
| WO-2021048381-A1 | METHOD FOR IDENTIFYING STABLE MHC BINDING PEPTIDES USING MASS SPECTROMETRY | EVAXION BIOTECH APS (DK) | 2021-03-18 | — | — | WO | disclosed |
| EP-1234039-A2 | 85kDa NEISSERIAL ANTIGEN | Chiron Spa (IT) | 2002-08-28 | — | — | EP | disclosed |
| WO-2001038350-A2 | 85kDa NEISSERIAL ANTIGEN | CHIRON SPA (IT) | 2001-05-31 | — | — | WO | disclosed |
| EP-1042001-A1 | USE OF MICROPARTICLES COMBINED WITH SUBMICRON OIL-IN-WATER EMULSIONS | CHIRON CORPORATION (US) | 2000-10-11 | — | — | EP | disclosed |
| EP-1006999-A2 | USE OF SUBMICRON OIL-IN-WATER EMULSIONS WITH DNA VACCINES | Chiron Corporation (US) | 2000-06-14 | — | — | EP | disclosed |
| WO-1999030737-A1 | USE OF MICROPARTICLES COMBINED WITH SUBMICRON OIL-IN-WATER EMULSIONS | CHIRON CORPORATION (US) | 1999-06-24 | — | — | WO | disclosed |
| WO-1999002132-A2 | USE OF SUBMICRON OIL-IN-WATER EMULSIONS WITH DNA VACCINES | CHIRON CORPORATION (US) | 1999-01-21 | — | — | WO | disclosed |
| EP-0582672-A4 | METHODS TO DETECT AND TREAT DISEASES CAUSED BY BACTERIAL ALLERGENS | CALENOFF EMANUEL (US) | 1994-06-29 | — | — | EP | disclosed |
| EP-0582672-A1 | METHODS TO DETECT AND TREAT DISEASES CAUSED BY BACTERIAL ALLERGENS | CALENOFF, Emanuel (US) | 1994-02-16 | — | — | EP | disclosed |
| WO-1992019970-A1 | METHODS TO DETECT AND TREAT DISEASES CAUSED BY BACTERIAL ALLERGENS | CALENOFF EMANUEL (US) | 1992-11-12 | — | — | WO | disclosed |
| EP-0315153-A2 | Vaccine adjuvant | SYNTEX (U.S.A.) INC. (US) | 1989-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250345410-A1 | VACCINATION IN NEWBORNS AND INFANTS | HLA-DRB1, TLR3, TLR9 | CTSC 2401/4885NOD1 1717/4885GABRP 3806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.